https://yatiribio.com/2020/09/30/proteogenomic-reveals-colon-therapeutics/2026-01-27T15:44:57+00:00https://yatiribio.com/2020/09/30/pan-cancer-proteomic-subtypes/2026-01-27T15:44:50+00:00https://yatiribio.com/2020/09/30/medulloblastoma-subgroup-molecular-heterogeneity/2026-01-27T15:45:05+00:00https://yatiribio.com/2020/09/30/proteogenomic-breast-cancer/2026-01-27T15:45:11+00:00https://yatiribio.com/2025/10/31/pan-cancer-proteomic-subtypes-2/2026-01-27T15:44:34+00:00https://yatiribio.com/2025/11/29/dr-afshin-bahador-from-south-coast-gynecologic-oncology-inc/2026-01-27T15:44:42+00:00https://yatiribio.com/2025/11/29/yatiri-bio-was-selected-as-a-2023-cool-company/2026-01-27T15:44:26+00:00https://yatiribio.com/2025/11/29/yatiri-bio-was-selected-as-a-2023-cool-companyyatiri-bio-and-fred-hutch-cancer-center-fhcc/2026-01-27T15:44:19+00:00https://yatiribio.com/2025/11/29/yatiri-bio-inc-attended-the-65th-annual-american-society-for-hematology/2026-01-27T15:44:10+00:00https://yatiribio.com/2025/11/29/michael-j-kamdar-joins-yatiri-bios-strategic-advisory-board/2026-01-27T15:44:03+00:00https://yatiribio.com/2025/11/29/dr-carl-goldfisher-joins-yatiri-bios-strategic-advisory-board/2026-01-27T15:43:53+00:00https://yatiribio.com/2025/11/29/dr-jennifer-van-eyk-has-joins-yatiri-bios-advisory-board/2026-01-27T15:43:46+00:00https://yatiribio.com/2025/11/29/yatiri-bio-acquires-ngenebioai-to-expand-ai-powered-proteomics/2026-01-27T15:43:38+00:00https://yatiribio.com/2025/11/29/yatiri-bio-receives-grant-to-advance-proteomics-interoperability-in-cancer-research/2026-04-22T21:10:39+00:00https://yatiribio.com/2026/01/27/american-society-of-hematology-ash-annual-meeting-exposition-hematology-org/2026-01-27T14:53:29+00:00https://yatiribio.com/2026/01/27/determining-sensitivity-to-flt3-inhibitors-prior-to-therapy-in-flt3-mutant-acute-myelogenous-leukemia/2026-01-27T14:50:42+00:00https://yatiribio.com/2026/01/27/machine-learning-powered-integration-of-global-proteomics-and-ex-vivo-sensitivity/2026-01-27T14:51:01+00:00https://yatiribio.com/2026/01/27/plasma-proteomics-using-mag-net-and-proteograph-xt-enrichment-enables-multi-faceted-biomarker-discovery-with-complementary-protein-and-peptide-coverage/2026-01-27T14:52:58+00:00https://yatiribio.com/2026/01/27/personalized-therapeutic-prediction-in-aml-via-proteomics-informed-deep-learning/2026-01-27T14:48:36+00:00https://yatiribio.com/2026/01/27/predicting-drug-response-heterogeneity-in-aml-novel-ai-enabled-proteomics-model-for-a-prospective-clinical-trial/2026-01-27T14:49:29+00:00https://yatiribio.com/2026/01/27/deep-learning-driven-proteomics-mapping-to-unveil-acute-myeloid-leukemia-therapeutic-sensitivity-and-guide-precision-treatment-strategies/2026-01-27T14:59:02+00:00https://yatiribio.com/2026/02/10/yatiri-bio-accurately-predicts-aml-drug-response-in-blinded-study-using-foghorns-fhd-286/2026-04-22T21:34:01+00:00https://yatiribio.com/2026/03/24/yatiri-bio-enters-exclusive-option-to-in-license-agreement-with-oscotec-for-denfivontinib-in-aml/2026-04-22T21:35:10+00:00